Innovation Saving Lives

We are a biotechnology company with a proprietary biomarker discovery platform, EpiSwitch™, based on the latest advances in gene expression,non-coding RNA and epigenetics.

Episwitch™ biomarkers based on chromosomal conformation signatures are a critical cog in personalised medicine.

Technology to select the right drug at the right dose at the right time for the right patient.

Recent Publications on Chromosome Conformation Signatures


Cocaine-Induced Chromatin Modifications Associate With Increased Expression and Three-Dimensional Looping of Auts2.

Engmann O et. al.
Biol Psychiatry
https://www.ncbi.nlm.nih.gov/pubmed/28577753

Nucleome Analysis Reveals Structure-function Relationships for Colon Cancer.

Seaman L et. al.
Mol Cancer Res.
https://www.ncbi.nlm.nih.gov/pubmed/28258094

Topologically associated domains: a successful scaffold for the evolution of gene regulation in animals.

Acemel RD et. al.
Wiley Interdiscip Rev Dev Biol.
https://www.ncbi.nlm.nih.gov/pubmed/28251841

Software tools for visualizing Hi-C data.

Yardimici GG et. al.
Genome Biology
https://www.ncbi.nlm.nih.gov/pubmed/28159004

Capturing genomic relationships that matter.

Osborne CS et. al.
Chromosome Research
https://www.ncbi.nlm.nih.gov/pubmed/28078515